SCHEMBL2654791

SCHEMBL2654791

COC(=O)c1cc2c(cc1Br)C(=O)CCO2.COC(=O)c1cc2c(cc1Br)C(=O)CCO2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
KDM4E B2RXH2 3/20 0.48
MAOB P27338 6/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
MAOA P21397 1/20 0.43
GRM5 P41594 5/20 0.42
HPGD P15428 2/20 0.38
L3MBTL4 Q8NA19 1/20 0.36
MAPT P10636 2/20 0.36
MEN1 O00255 1/20 0.36
TP53 P04637 1/20 0.36
POLB P06746 1/20 0.36
KMT2A Q03164 1/20 0.36
TSHR P16473 1/20 0.36
GPR119 Q8TDV5 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2878771 1.00 ALDH1A1 (0.48) ALDH1A1KDM4EMAOBSMN1; SMN2MAOA
SCHEMBL12366007 0.81 KDM4E (0.44) ALDH1A1KDM4EMAOBSMN1; SMN2MAOA
SCHEMBL1279441 0.81 KDM4E (0.66) ALDH1A1KDM4ESMN1; SMN2HPGDL3MBTL4
SCHEMBL16333691 0.78 MAOB (0.45) ALDH1A1KDM4EMAOBSMN1; SMN2MAOA
SCHEMBL23363326 0.75 MAOB (0.45) ALDH1A1KDM4EMAOBSMN1; SMN2MAOA
SCHEMBL31457765 0.75 MAOB (0.45) ALDH1A1KDM4EMAOBSMN1; SMN2MAOA
SCHEMBL552716 0.74 GRM5 (0.56) ALDH1A1KDM4EMAOBSMN1; SMN2MAOA
SCHEMBL29446216 0.74 GRM5 (0.47) ALDH1A1KDM4EMAOBSMN1; SMN2MAOA
SCHEMBL670311 0.74 GRM5 (0.47) ALDH1A1KDM4EMAOBSMN1; SMN2MAOA
SCHEMBL17782662 0.74 KDM4E (0.53) ALDH1A1KDM4ESMN1; SMN2HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1868985-A2 GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE Merck & Co., Inc. (US) 2007-12-26 EP disclosed
WO-2006104826-A2 GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK & CO., INC. (US) 2006-10-05 WO disclosed